Revision 1

#58891Store at -20C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IP

REACTIVITY:

H M R Mk

SENSITIVITY:

Endogenous

MW (kDa):

52

Source/Isotype:

Rabbit IgG

UniProt ID:

#P31260

Entrez-Gene Id:

3206

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunoprecipitation 1:50

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

HoxA10 (E5X4L) Rabbit mAb recognizes endogenous levels of total HoxA10 protein. This antibody detects a band of unknown origin around 32 kDa.

Species Reactivity:

Human, Mouse, Rat, Monkey

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu188 of human HoxA10 protein.

Background

HOXA10 is a member of the HOXA cluster which, along with the HOXB, HOXC, and HOXD clusters, governs embryonic patterning along the cranio-caudal axis (1,2). HOXA10 was originally identified in hematopoietic cells, where it is alternatively spliced into two isoforms, the larger being expressed in early stages of myeloid differentiation (2,3). Expression of HOXA10 can be regulated by estrogen and progesterone and is important for uterine implantation (4-6). HOXA10 is a transcription factor that partners with Pbx proteins to bind DNA, and this process can be affected by tyrosine phosphorylation (7,8). Overexpression of HOXA10 has been shown to contribute to acute myeloid leukemia and is associated with poor prognosis (9,10).

  1. McGinnis, W. and Krumlauf, R. (1992) Cell 68, 283-302.
  2. Lowney, P. et al. (1991) Nucleic Acids Res 19, 3443-9.
  3. Lawrence, H.J. et al. (1995) Exp Hematol 23, 1160-6.
  4. Taylor, H.S. et al. (1998) J Clin Invest 101, 1379-84.
  5. Taylor, H.S. et al. (1999) Hum Reprod 14, 1328-31.
  6. Lim, H. et al. (1999) Mol Endocrinol 13, 1005-17.
  7. Chang, C.P. et al. (1995) Genes Dev 9, 663-74.
  8. Eklund, E.A. et al. (2000) J Biol Chem 275, 20117-26.
  9. Thorsteinsdottir, U. et al. (1997) Mol Cell Biol 17, 495-505.
  10. Guo, C. et al. (2020) BMC Cancer 20, 586.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IP: Immunoprecipitation

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

Revision 1
#58891

HoxA10 (E5X4L) Rabbit mAb

Western Blotting Image 1: HoxA10 (E5X4L) Rabbit mAb Expand Image
Western blot analysis of extracts from various cell lines using HoxA10 (E5X4L) Rabbit mAb (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower).
Immunoprecipitation Image 1: HoxA10 (E5X4L) Rabbit mAb Expand Image
Immunoprecipitation of HoxA10 protein from 293T cell extracts. Lane 1 is 10% input, lane 2 is Rabbit (DA1E) mAb IgG XP® Isotype Control #3900, and lane 3 is HoxA10 (E5X4L) Rabbit mAb. Western blot analysis was performed using HoxA10 (E5X4L) Rabbit mAb. Mouse Anti-rabbit IgG (Conformation Specific) (L27A9) mAb (HRP Conjugate) #5127 was used as a secondary antibody.